What does Histogenex Holding do?
HistoGeneX Holding specializes in providing advanced diagnostic services in the field of oncology. The company focuses on developing and delivering innovative solutions for precision medicine through histopathology and molecular diagnostics. Its aim is to enhance patient care and outcomes by facilitating personalized treatment strategies.
- Sectors
- Consultancy firms Holding companies
- Activities
- Signals
-
ProfitableProfitable € 25K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 65.86MStrong equity provides a buffer against setbacks.
Low riskLow risk 99.2%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.81A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 25KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 29KPositive EBITDA: operating activities are profitable.
High turnoverHigh turnover € 1.02MSubstantial turnover in the latest financial year.
- Investments
- Cellcarta 83,33%
Financial ratios
|
|
2025
|
2024
|
2023
|
2022
|
|---|---|---|---|---|
|
€
1.02M
|
€
888K
|
€
871K
|
-
|
|
|
€
29K
|
€
121K
|
€
130K
|
€
136K
|
|
|
€
25K
|
€
118K
|
€
126K
|
€
132K
|
|
|
€
65.86M
|
€
65.83M
|
€
65.71M
|
€
65.59M
|
|
|
99.21%
|
99.60%
|
99.64%
|
99.59%
|
|
|
€
522K
|
€
263K
|
€
235K
|
€
269K
|
|
|
€
174K
|
€
166K
|
€
178K
|
€
182K
|
Publications 22
All publications- Ontslagen - Benoemingen 06/12/2023
- Ontslagen - Benoemingen 27/02/2023
- Ontslagen - Benoemingen 02/08/2022
- Ontslagen - Benoemingen 19/04/2022
- Statuten (Vertaling, Cordinatie, Overige Wijzigingen, ) - Kapitaal - Aandelen 29/05/2020
News
Show all- Mosaic Laboratories Acquired By Caprion-Histogenex, Transaction Will Fuel Global Expansion And Services To Pharmaceutical Clients On Larger Scale Yahoo Finance 5 years ago
- Caprion Biosciences And Histogenex Unite Businesses To Create Global Leader In Immune Monitoring And Biomarker Development PR Newswire 7 years ago
Frequently asked questions
Answers to the most common questions about Histogenex Holding, based on official government data and the filed annual accounts.
What is the VAT number of Histogenex Holding?
The VAT number of Histogenex Holding is BE0643.686.060.
What is the official website of Histogenex Holding?
The official website of Histogenex Holding is http://www.histogeninc.com.
When was Histogenex Holding established?
Histogenex Holding was founded in 27-11-2015.
What is the official address of Histogenex Holding?
The official address of Histogenex Holding is Sint-Bavostraat 78 Antwerpen 2610.
What is the legal form of Histogenex Holding?
The juridical form of Histogenex Holding is Public limited company (NV/SA).
What is the annual revenue of Histogenex Holding?
The revenue of Histogenex Holding for the 2025 financial year was €1,016,247.
What does Histogenex Holding do?
HistoGeneX Holding specializes in providing advanced diagnostic services in the field of oncology. The company focuses on developing and delivering innovative solutions for precision medicine through histopathology and molecular diagnostics. Its aim is to enhance patient care and outcomes by facilitating personalized treatment strategies.
Is Histogenex Holding a reliable company?
Histogenex Holding is a registered Rechtspersoon with company number 0643.686.060 and can be verified through the official CBE database.
What is the credit limit of Histogenex Holding?
The estimated credit limit of Histogenex Holding is €3,238,653.
Is Histogenex Holding still active?
Histogenex Holding currently has the status "Normal situation" and is active.